To further extend its reach in the digital health market, Google is teaming-up with Sanofi to develop tools that improve the management and treatment of diabetes.
The French drug maker will work with Google’s life sciences team to collect, analyze and understand information impacting diabetes, which is expected to affect 592 million by 2035, according to the International Diabetes Federation.
Sanofi’s diabetes product line raked in sales of 1.9 billion Euros ($2.13 billion), contributing about 20 percent to the company’s total sales in the second quarter. However, the sales have been hurt by continued pricing pressure in the United States.
This is not Google’s first partnership to tackle diabetes. The search giant has previously partnered with Novartis to develop a smart contact lens that can track blood glucose levels and/or restore the eye’s ability to focus. Also, it is working with DexCom, a maker of continuous glucose-monitoring (CGM) devices, to create a device the size of a band-aid that can be worn on the skin.
Google’s life sciences division has recently been spun out as a separate company under the Alphabet umbrella.